(Total Views: 667)
Posted On: 02/07/2021 2:15:02 PM
Post# of 155001
Treating Covid might not be moving on to cancer.
Treating Covid migth be treating cancer.
Tens of thousands of Covid leronlimab patients will have cancer.
If you treat Covid with leronlimab, you will treat more than ten times as many cancer patients as all future Leronlimab cancer human clinical trials combined.
Of course the Covid cancer patients are likely only guaranteed two doses.
But in a few short weeks after Covid approval, if achieved, Cytodyn will be making a lot of noise about cancer.
Even the least up-to-date physician will realize his cancer patient with Covid might benefit from a few extra doses of leronlimab.
Most of these physicians probably won't even bother with the Patterson-type diagnostics for a projection of leronlimab on the cancer. They will just order a few extra doses. Because they can.
Treating Covid migth be treating cancer.
Tens of thousands of Covid leronlimab patients will have cancer.
If you treat Covid with leronlimab, you will treat more than ten times as many cancer patients as all future Leronlimab cancer human clinical trials combined.
Of course the Covid cancer patients are likely only guaranteed two doses.
But in a few short weeks after Covid approval, if achieved, Cytodyn will be making a lot of noise about cancer.
Even the least up-to-date physician will realize his cancer patient with Covid might benefit from a few extra doses of leronlimab.
Most of these physicians probably won't even bother with the Patterson-type diagnostics for a projection of leronlimab on the cancer. They will just order a few extra doses. Because they can.
(8)
(0)
